TAVR update: Contemporary data from the UK TAVI and US TVT registries

Authors

  • Hussam S Suradi 1. Rush Center for Congenital & Structural Heart Disease, Rush University Medical Center, Chicago, IL, USA 2. St Mary Medical Center, Community HealthCare Network, Hobart, IN, USA
  • Ziyad M Hijazi 2. St Mary Medical Center, Community HealthCare Network, Hobart, IN, USA 3. Sidra Cardiovascular Center of Excellence, Sidra Medical & Research Center, Doha, Qatar

Abstract

[first paragraph of article]

The introduction of transcatheter aortic valve replacement (TAVR in US - TAVI in Europe) has resulted in a paradigm shift in the treatment of patients with severe aortic stenosis. Although three randomized trials and multiple single-center and multicenter registry studies have been published, the profile and longer-term outcome of patients undergoing transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis have been limited. The recently published reports from the United Kingdom (UK) and United States (US) TAVR registries add tremendously to the currently available literature. These studies provide an excellent model to clinicians that would aid in the proper patient selection and help in guiding discussions with patients who are undergoing TAVR. The present review discusses the recently published UK and US TAVR registry data.

Downloads

Published

2017-08-22

Issue

Vol. 2015 No. 2 (2015)

Section

Lessons from the trials

License

This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.